LYNN WHITTAKER: Open Payments
NPI 1114367299 · STATE COLLEGE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,933 in 77 payments from 36 companies in 2025. Trend: 2023 $0 · 2024 $971 · 2025 $1,933
Food & beverage: $1,917Education: $16
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 7 | $200 |
| Ipsen Biopharmaceuticals, Inc | 1 | $195 |
| PFIZER INC. | 5 | $180 |
| E.R. Squibb & Sons, L.L.C. | 9 | $147 |
| Regeneron Healthcare Solutions, Inc. | 3 | $105 |
| ABBVIE INC. | 3 | $77 |
| Merck Sharp & Dohme LLC | 3 | $72 |
| Stemline Therapeutics Inc. | 4 | $63 |
| Novartis Pharmaceuticals Corporation | 4 | $63 |
| BeOne Medicines USA, Inc. | 3 | $59 |
Products named: Onivyde, Enhertu, BOSULIF, LIBTAYO, OPDIVO, BRUKINSA, ELZONRIS, Epkinly.
Industry payments across PA — which companies pay providers there.
